Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for Canada
Recent activity on plant breeders' rights in Canada Recent activity on plant breeders' rights in Canada Reviewed by Jocelyn Bosse on Saturday, June 13, 2026 Rating: 5
Fordham 33 (Report 9): Sports, media and entertainment Fordham 33 (Report 9): Sports, media and entertainment Reviewed by Annsley Merelle Ward on Monday, April 27, 2026 Rating: 5

Friday Fantasies

It was back-to-school week for this Kat , but she still found time to sniff around for the latest IP news that might interest our readers. T...
- Friday, September 19, 2025
Friday Fantasies Friday Fantasies Reviewed by Jocelyn Bosse on Friday, September 19, 2025 Rating: 5
The Plant IP Year in Review 2024 The Plant IP Year in Review 2024 Reviewed by Jocelyn Bosse on Saturday, December 28, 2024 Rating: 5
Copyrighting the Ogopogo Monster: The © story behind the news story Copyrighting the Ogopogo Monster: The © story behind the news story Reviewed by Neil Wilkof on Tuesday, November 01, 2022 Rating: 5
Are diagnostic methods patentable? Are diagnostic methods patentable? Reviewed by Dr Rose Hughes on Monday, November 01, 2021 Rating: 5

Around the IP Blogs

This Kat is feeling wistful With temperatures heating up for Northern Hemisphere Kat friends, why not stay cool and take a look around the I...
- Wednesday, June 02, 2021
Around the IP Blogs Around the IP Blogs Reviewed by Sophie Corke on Wednesday, June 02, 2021 Rating: 5
Never Too Late: if you missed the IPKat last week Never Too Late: if you missed the IPKat last week Reviewed by Sophie Corke on Monday, February 08, 2021 Rating: 5
Canadian Federal Court considers whether Teva's COPAXONE second medical use patents were obvious-to-try (Teva v Pharmascience) Canadian Federal Court considers whether Teva's COPAXONE second medical use patents were obvious-to-try (Teva v Pharmascience) Reviewed by Dr Rose Hughes on Monday, January 25, 2021 Rating: 5

Around the IP Blogs

Beauty is in the eye of the (cat) beholder Patents  The Patently-O Blog featured a guest post by Profs. Jorge L. Conteras and Yang Yu, who ...
- Sunday, November 01, 2020
Around the IP Blogs Around the IP Blogs Reviewed by Anastasiia Kyrylenko on Sunday, November 01, 2020 Rating: 5
Study on the implications of a 25-year reversion/termination right in Canada Study on the implications of a 25-year reversion/termination right in Canada Reviewed by Nedim Malovic on Sunday, March 15, 2020 Rating: 5
Guest Post: Copyright Troll-[ing] Canadian Courts? Canada’s First Reverse Class Action Copyright Case Guest Post: Copyright Troll-[ing] Canadian Courts? Canada’s First Reverse Class Action Copyright Case Reviewed by Hayleigh Bosher on Tuesday, September 24, 2019 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.